Skip to main content
Top
Published in: Acta Diabetologica 4/2011

01-12-2011 | Original Article

Lipid partitioning after uninephrectomy

Authors: Hai-Lu Zhao, Yi Sui, Lan He, Jing Guan, Sheng-Jun Xiao, Ding-Rong Zhong, Qing Xu, Si-En Zeng

Published in: Acta Diabetologica | Issue 4/2011

Login to get access

Abstract

This longitudinal study addressed the sequential events and metabolic consequences of lipid partitioning following uninephrectomy. Adult male Sprague–Dawley rats were randomized into sham operation (n = 15) or left uninephrectomy (UNX, n = 18). At 1 and 3 months post nephrectomy, three rats from each group were killed for histopathological examination of adipocyte differentiation and lipid accumulation. Renal protein expression of the lipogenic peroxisome proliferator-activated receptor-γ (PPAR-γ), HMG-CoA reductase (HMGCR), and adiponectin receptor was detected by Western blot and immunofluorescence microscopy. Blood lipids, glucose, insulin, and renal functions were longitudinally measured up to 10 months after operation. The UNX rats progressively developed lipodystrophy of subcutaneous and visceral adipose depots with failure of adipocyte differentiation and lipid storage, followed by blood lipid elevation and ectopic lipid deposition with cellular lipid peroxidation, and renal adipogenesis with chronic inflammatory infiltration. Despite having standard diet, normal food consumption and normal body weight, the uninephrectomized rats with defective lipid partitioning manifested a myriad of homeostatic disturbances including insulin resistance, hyperglycemia, adiponectin resistance, and upregulation of PPAR-γ and HMGCR. Abnormal lipid partitioning from adipose depots to circulation and non-adipose tissues and non-adipocytic cells contributes to homeostatic disturbances and lipogenic activation.
Literature
1.
go back to reference Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28(Suppl 4):S58–S65PubMedCrossRef Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28(Suppl 4):S58–S65PubMedCrossRef
2.
go back to reference Unger RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159–5165PubMedCrossRef Unger RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159–5165PubMedCrossRef
4.
go back to reference Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509PubMedCrossRef Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509PubMedCrossRef
5.
go back to reference Javor ED, Moran SA, Young JR, Cochran EK, DePaoli AM, Oral EA, Turman MA, Blackett PR, Savage DB, O’Rahilly S, Balow JE, Gorden P (2004) Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab 89:3199–3207PubMedCrossRef Javor ED, Moran SA, Young JR, Cochran EK, DePaoli AM, Oral EA, Turman MA, Blackett PR, Savage DB, O’Rahilly S, Balow JE, Gorden P (2004) Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab 89:3199–3207PubMedCrossRef
6.
go back to reference Avram AS, Avram MM, James WD (2005) Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol 53:671–683PubMedCrossRef Avram AS, Avram MM, James WD (2005) Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol 53:671–683PubMedCrossRef
7.
8.
go back to reference Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281:31–35PubMedCrossRef Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281:31–35PubMedCrossRef
9.
go back to reference Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611–617PubMedCrossRef Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611–617PubMedCrossRef
10.
go back to reference Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147–1156PubMedCrossRef Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147–1156PubMedCrossRef
11.
go back to reference Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319:24–33PubMedCrossRef Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319:24–33PubMedCrossRef
12.
go back to reference Sui Y, Zhao HL, Ma RC, Ho CS, Kong AP, Lai FM, Ng HK, Rowlands DK, Chan JC, Tong PC (2007) Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy. Cell Mol Life Sci 64:3119–3128PubMedCrossRef Sui Y, Zhao HL, Ma RC, Ho CS, Kong AP, Lai FM, Ng HK, Rowlands DK, Chan JC, Tong PC (2007) Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy. Cell Mol Life Sci 64:3119–3128PubMedCrossRef
13.
go back to reference Zhao HL, Sui Y, Guan J, He L, Zhu X, Fan RR, Xu G, Kong AP, Ho CS, Lai FM, Rowlands DK, Chan JC, Tong PC (2008) Fat redistribution and adipocyte transformation in uninephrectomized rats. Kidney Int 74:467–477PubMedCrossRef Zhao HL, Sui Y, Guan J, He L, Zhu X, Fan RR, Xu G, Kong AP, Ho CS, Lai FM, Rowlands DK, Chan JC, Tong PC (2008) Fat redistribution and adipocyte transformation in uninephrectomized rats. Kidney Int 74:467–477PubMedCrossRef
14.
go back to reference Asensi V, Martin-Roces E, Carton JA, Collazos J, Maradona JA, Alonso A, Medina M, Aburto JM, Martinez E, Rojo C, Bustillo E, Fernandez C, Arribas JM (2004) Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 39:240–247PubMedCrossRef Asensi V, Martin-Roces E, Carton JA, Collazos J, Maradona JA, Alonso A, Medina M, Aburto JM, Martinez E, Rojo C, Bustillo E, Fernandez C, Arribas JM (2004) Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 39:240–247PubMedCrossRef
15.
go back to reference Danforth E Jr (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13PubMedCrossRef Danforth E Jr (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13PubMedCrossRef
16.
go back to reference Campbell DJ, Kladis A, Duncan AM (1993) Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 22:513–522PubMed Campbell DJ, Kladis A, Duncan AM (1993) Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 22:513–522PubMed
17.
go back to reference Ikonen E (2006) Mechanisms for cellular cholesterol transport: defects and human disease. Physiol Rev 86:1237–1261PubMedCrossRef Ikonen E (2006) Mechanisms for cellular cholesterol transport: defects and human disease. Physiol Rev 86:1237–1261PubMedCrossRef
18.
go back to reference Zhao B, Fisher BJ, St Clair RW, Rudel LL, Ghosh S (2005) Redistribution of macrophage cholesteryl ester hydrolase from cytoplasm to lipid droplets upon lipid loading. J Lipid Res 46:2114–2121PubMedCrossRef Zhao B, Fisher BJ, St Clair RW, Rudel LL, Ghosh S (2005) Redistribution of macrophage cholesteryl ester hydrolase from cytoplasm to lipid droplets upon lipid loading. J Lipid Res 46:2114–2121PubMedCrossRef
19.
go back to reference Daumerie CM, Woollett LA, Dietschy JM (1992) Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc Natl Acad Sci USA 89:10797–10801PubMedCrossRef Daumerie CM, Woollett LA, Dietschy JM (1992) Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc Natl Acad Sci USA 89:10797–10801PubMedCrossRef
20.
go back to reference Voelker DR (1991) Organelle biogenesis and intracellular lipid transport in eukaryotes. Microbiol Rev 55:543–560PubMed Voelker DR (1991) Organelle biogenesis and intracellular lipid transport in eukaryotes. Microbiol Rev 55:543–560PubMed
21.
go back to reference Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND (2009) Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296:F1297–F1306PubMedCrossRef Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND (2009) Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296:F1297–F1306PubMedCrossRef
22.
go back to reference Heuck CC, Liersch M, Ritz E, Stegmeier K, Wirth A, Mehls O (1978) Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat. Kidney Int 14:142–150PubMedCrossRef Heuck CC, Liersch M, Ritz E, Stegmeier K, Wirth A, Mehls O (1978) Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat. Kidney Int 14:142–150PubMedCrossRef
23.
go back to reference Nagase S, Aoyagi K, Gotoh M, Hirayama A, Tomida C, Shimozawa Y, Koyama A (1996) Increased lipid peroxidation by rat liver microsomes in experimental renal failure. Nephron 74:204–208PubMedCrossRef Nagase S, Aoyagi K, Gotoh M, Hirayama A, Tomida C, Shimozawa Y, Koyama A (1996) Increased lipid peroxidation by rat liver microsomes in experimental renal failure. Nephron 74:204–208PubMedCrossRef
24.
go back to reference Naito M, Bomsztyk K, Zager RA (2009) Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene. Am J Pathol 174:54–62PubMedCrossRef Naito M, Bomsztyk K, Zager RA (2009) Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene. Am J Pathol 174:54–62PubMedCrossRef
25.
go back to reference Liang K, Vaziri ND (1997) Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure. Nephrol Dial Transplant 12:1381–1386PubMedCrossRef Liang K, Vaziri ND (1997) Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure. Nephrol Dial Transplant 12:1381–1386PubMedCrossRef
26.
go back to reference Kida K, Nakajo S, Kamiya F, Toyama Y, Nishio T, Nakagawa H (1978) Renal net glucose release in vivo and its contribution to blood glucose in rats. J Clin Invest 62:721–726PubMedCrossRef Kida K, Nakajo S, Kamiya F, Toyama Y, Nishio T, Nakagawa H (1978) Renal net glucose release in vivo and its contribution to blood glucose in rats. J Clin Invest 62:721–726PubMedCrossRef
27.
go back to reference McGuinness OP, Fugiwara T, Murrell S, Bracy D, Neal D, O’Connor D, Cherrington AD (1993) Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol 265:E314–E322PubMed McGuinness OP, Fugiwara T, Murrell S, Bracy D, Neal D, O’Connor D, Cherrington AD (1993) Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol 265:E314–E322PubMed
28.
go back to reference Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J (1995) Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest 96:2528–2533PubMedCrossRef Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J (1995) Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest 96:2528–2533PubMedCrossRef
29.
go back to reference Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, Rosas-Arellano MP, Housawi A, Garg AX (2006) Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 145:185–196PubMed Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, Rosas-Arellano MP, Housawi A, Garg AX (2006) Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 145:185–196PubMed
30.
31.
go back to reference Cheung AK, Wu LL, Kablitz C, Leypoldt JK (1993) Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 22:271–276PubMed Cheung AK, Wu LL, Kablitz C, Leypoldt JK (1993) Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 22:271–276PubMed
32.
go back to reference Odamaki M, Furuya R, Ohkawa S, Yoneyama T, Nishikino M, Hishida A, Kumagai H (1999) Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 14:2427–2432PubMedCrossRef Odamaki M, Furuya R, Ohkawa S, Yoneyama T, Nishikino M, Hishida A, Kumagai H (1999) Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 14:2427–2432PubMedCrossRef
33.
go back to reference Solomon LR, Mallick NP, Lawler W (1985) Progressive renal failure in a remnant kidney. Br Med J (Clin Res Ed) 291:1610–1611CrossRef Solomon LR, Mallick NP, Lawler W (1985) Progressive renal failure in a remnant kidney. Br Med J (Clin Res Ed) 291:1610–1611CrossRef
34.
go back to reference Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM (2009) Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol 4:1230–1238PubMedCrossRef Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM (2009) Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol 4:1230–1238PubMedCrossRef
35.
go back to reference Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ (2009) Long-term consequences of kidney donation. N Engl J Med 360:459–469PubMedCrossRef Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ (2009) Long-term consequences of kidney donation. N Engl J Med 360:459–469PubMedCrossRef
36.
go back to reference Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMedCrossRef Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMedCrossRef
37.
go back to reference Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113:1582–1588PubMed Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113:1582–1588PubMed
38.
go back to reference Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784–2791PubMedCrossRef Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784–2791PubMedCrossRef
39.
go back to reference Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M, Reitman ML (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271–278PubMedCrossRef Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M, Reitman ML (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271–278PubMedCrossRef
40.
go back to reference Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410–420PubMedCrossRef Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410–420PubMedCrossRef
41.
go back to reference Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z (2003) PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol 14:593–600PubMedCrossRef Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z (2003) PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol 14:593–600PubMedCrossRef
42.
go back to reference Fiorentino L, Vivanti A, Cavalera M, Marzano V, Ronci M, Fabrizi M, Menini S, Pugliese G, Menghini R, Khokha R, Lauro R, Urbani A, Federici M (2010) Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51:103–110PubMedCrossRef Fiorentino L, Vivanti A, Cavalera M, Marzano V, Ronci M, Fabrizi M, Menini S, Pugliese G, Menghini R, Khokha R, Lauro R, Urbani A, Federici M (2010) Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51:103–110PubMedCrossRef
43.
go back to reference Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, Tornei F, Bertucci P, Iacobini C, Serino M, Porzio O, Hribal ML, Folli F, Khokha R, Urbani A, Lauro R, Pugliese G, Federici M (2009) Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136:663–672.e4PubMedCrossRef Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, Tornei F, Bertucci P, Iacobini C, Serino M, Porzio O, Hribal ML, Folli F, Khokha R, Urbani A, Lauro R, Pugliese G, Federici M (2009) Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136:663–672.e4PubMedCrossRef
44.
go back to reference Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R, Federici M (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524–1532PubMedCrossRef Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R, Federici M (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524–1532PubMedCrossRef
45.
go back to reference Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro D, Sbraccia P, Lauro R, Federici M (2005) Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 111:1946–1953PubMedCrossRef Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro D, Sbraccia P, Lauro R, Federici M (2005) Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 111:1946–1953PubMedCrossRef
46.
go back to reference Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z (2010) The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z (2010) The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol
47.
go back to reference Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Erem C (2011) The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Erem C (2011) The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol
48.
go back to reference Pitocco D, Giubilato S, Zaccardi F, Di Stasio E, Buffon A, Biasucci LM, Liuzzo G, Crea F, Ghirlanda G (2009) Pioglitazone reduces monocyte activation in type 2 diabetes. Acta Diabetol 46:75–77PubMedCrossRef Pitocco D, Giubilato S, Zaccardi F, Di Stasio E, Buffon A, Biasucci LM, Liuzzo G, Crea F, Ghirlanda G (2009) Pioglitazone reduces monocyte activation in type 2 diabetes. Acta Diabetol 46:75–77PubMedCrossRef
Metadata
Title
Lipid partitioning after uninephrectomy
Authors
Hai-Lu Zhao
Yi Sui
Lan He
Jing Guan
Sheng-Jun Xiao
Ding-Rong Zhong
Qing Xu
Si-En Zeng
Publication date
01-12-2011
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2011
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0286-9

Other articles of this Issue 4/2011

Acta Diabetologica 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.